NGT BioPharma Consultants

Menu
Contact Us

News

News
NGT BioPharma Consultants Welcomes Roger Nosal, Head of Regulatory Strategy
NGT BioPharma Consultants Welcomes Roger Nosal. Prior to September 2022 he was Vice President & Head of Global Chemistry, Manufacturing & Controls at Pfizer where...
News
NGT BioPharma Consultants At the 2022 ISPE Annual Expo!
News
NGT BioPharma Consultants Welcomes Jim Weber, Strategist CMC Biologics
NGT BioPharma Consultants Welcomes Jim Weber, Strategist CMC
News
NGT BioPharma Consultants Welcomes Daniel Schaufelberger, VP Chemistry, Manufacturing, & Control (CMC)
NGT BioPharma Consultants Welcomes Daniel Schaufelberger, VP CMC and Specialist in Pediatric Drug Development.
News
NGT BioPharma Consultants Welcomes Michelle McGuinness, VP Regulatory Strategy & Submissions
NGT BioPharma Consultants Welcomes Michelle McGuinness, VP Regulatory Strategy & Submissions
News
Dr. Robert Dennehy is Appointed to Strategic Advisory Board at CatSci
NGT BioPharma's Dr. Robert Dennehy is appointed to Strategic Advisory Board at CatSci.
News
Meet Robert Dennehy, Crystallization and Solid-State Subject Matter Expert
Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today...
News
Meet Malcolm Berry, API Continuous Processing Subject Matter Expert
Our people are at the core of our business. We are featuring the amazing individuals who make NGT BioPharma Consultants a proficient and principled team to work with. Today...
News
Listen to NGT’s API Expert Malcolm Berry at the Pharma 4.0 eConference!
Listen to NGT’s API Expert Malcolm Berry at the Pharma 4.0 eConference!
News
Current State of the Market for Antimicrobial Resistant (AMR) Medicines
While the world focuses on COVID-19, NGT’s Michael K. O’Brien and Philip Chu provide insight on the current state of the market for antimicrobial resistant (AMR) medicines....



Page 1 of 2